Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Account Payables: 2022

Historic Change in Account Payables for Orchestra BioMed Holdings (OBIO) over the last 1 years, with Dec 2022 value amounting to $375,542.

  • Orchestra BioMed Holdings' Change in Account Payables was N/A to $95,369 in Q4 2022 from the same period last year, while for Dec 2022 it was $375,542, marking a year-over-year change of. This contributed to the annual value of $375,542 for FY2022, which is N/A change from last year.
  • According to the latest figures from FY2022, Orchestra BioMed Holdings' Change in Account Payables is $375,542.
  • Over the past 5 years, Orchestra BioMed Holdings' Change in Account Payables peaked at $375,542 during FY2022, and registered a low of $375,542 during FY2022.
  • In the last 1 years, Orchestra BioMed Holdings' Change in Account Payables had a median value of $375,542 in 2022 and averaged $375,542.